S&P 5007,482.58▼0.3% Nasdaq25,870.65▲0.2% Dow52,348.09▼1.1% Russell 2K2,948.91▼1.1% 10-Yr4.57%+4bp VIX16.86+0.73 WTI$74.03▲5.1% Gold$4,091.40▼1.3% EUR/USD1.143▼0.1% BTC$63,168▲1.5% Nikkei68,257▼2.1%
At close · Thu, Jul 9, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Drugmaker sheds $27 billion in market value after fail…

Drugmaker sheds $27 billion in market value after failed trial

Reported · Written up by our desk · Previews

A major drugmaker lost about $27 billion in market value after a trial failed, according to MarketWatch.

← Newer storyBitcoin spot ETFs log $85M net outflow after sell-off streak

More like this

EarningsKeyBanc downgrades Salesforce amid doubts about AI narrative
EarningsAstraZeneca shares fall after heart drug trial misses primary endpoint
EarningsAirline earnings head into the next earnings cycle
EarningsAstraZeneca shares fall after heart drug trial misses target
EarningsFedEx Freight discusses results on its first earnings call as a standalone

Sources

MarketWatchMajor drugmaker loses $27 billion in market value after failed trial
MarketWatchMajor drugmaker loses $27 billion in market value after failed trial

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.